Tailoring Recommendations for People Living With Type 2 Diabetes and Chronic Kidney Disease: The Role of the Pharmacist

This activity is part 3 in a 3-part webinar curriculum and includes patient counseling videos.

Program Description

The multidisciplinary care team is essential to providing comprehensive care to patients with diabetes and chronic kidney disease (CKD). As medication experts, pharmacists can have important roles in educating both clinicians and patients about new and emerging treatments, as well as adverse effects. Their involvement on the care team can also extend to recommendations for lifestyle modifications and interventions to assess medication adherence. As part of the health care team, pharmacists can fill the communication gaps between providers and patients to improve medication regimens and educate patients. This webinar includes pharmacist counseling video vignettes that will highlight communication skills and reinforce key concepts to optimize medication management for people living with diabetes and CKD. Strategies pharmacists can implement in practice to guide treatment and monitor recommendations for patients living with diabetes and CKD will be presented.

Target audience: Health-system, retail, and specialty pharmacists

Type of activity: Application
Release date: September 12, 2023
Expiration date: November 12, 2023

Time to complete activity: 1.0 hour

Learner level: Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify key barriers and strategies to optimize utilization of and access to guideline-recommended drug therapies in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD)

• Explain the role of the pharmacist within the multidisciplinary care team to educate patients, address barriers, and facilitate optimized management of patients with T2D and CKD

• Apply patient counseling techniques to promote safe and effective medication use in patients with T2D and CKD

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-23-310-L01-P. The activity is available for CE credit through November 12, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, has the following financial relationships with commercial interests to disclose:
Consultant: Sanofi, Bayer, Boehringer Ingelheim, Eli Lilly, Proteomics International

Speakers Bureau: DexCom Inc

The following contributors have no relevant financial relationships with commercial interests to disclose:

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Rush, PharmD; Angelica Archibald; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms